MwanzoONC • TSE
add
Oncolytics Biotech Inc
Bei iliyotangulia
$Â 1.22
Bei za siku
$Â 1.20 - $Â 1.22
Bei za mwaka
$Â 1.20 - $Â 3.03
Thamani ya kampuni katika soko
92.45M CAD
Wastani wa hisa zilizouzwa
elfu 45.11
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
.DJI
0.33%
0.13%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CAD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 7.92M | 10.61% |
Mapato halisi | -7.26M | 2.49% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.10 | 13.68% |
EBITDA | -7.89M | -10.55% |
Asilimia ya kodi ya mapato | -1.33% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(CAD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 24.85M | 2.05% |
Jumla ya mali | 32.07M | 0.32% |
Jumla ya dhima | 13.76M | 41.44% |
Jumla ya hisa | 18.31M | — |
hisa zilizosalia | 76.99M | — |
Uwiano wa bei na thamani | 5.08 | — |
Faida inayotokana na mali | -59.26% | — |
Faida inayotokana mtaji | -90.99% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(CAD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -7.26M | 2.49% |
Pesa kutokana na shughuli | -6.82M | 19.44% |
Pesa kutokana na uwekezaji | elfu -155.00 | -102.28% |
Pesa kutokana na ufadhili | 1.98M | -46.51% |
Mabadiliko halisi ya pesa taslimu | -4.75M | -388.41% |
Mtiririko huru wa pesa | -4.52M | 24.11% |
Kuhusu
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Ilianzishwa
1998
Makao Makuu
Tovuti
Wafanyakazi
29